A.M. Best Revises Outlooks to Negative for GBG Insurance Limited
The ratings reflect GBG’s strong balance sheet strength, strong operating performance, limited business profile and marginal enterprise risk management (ERM).
The outlooks have been revised to negative as GBG’s risk-adjusted capitalisation at year-end 2017 was at a lower level than anticipated due to the impact of a one-off impairment allowance equivalent to a quarter of the company’s capital base. While the retention of future earnings is expected to support improvement in GBG’s risk-adjusted capitalisation to the strongest level, as measured by Best’s Capital Adequacy Ratio (BCAR),
GBG’s balance sheet strength is underpinned by risk-adjusted capitalisation at the very strong level, as measured by BCAR, and the excellent quality of the company’s investment portfolio. However, the company’s capital base is relatively small, which makes its risk-adjusted capitalisation susceptible to fluctuations in its financial results and underwriting exposures. Risk associated with the company’s high reliance on reinsurance is partially offset by the good credit quality of its reinsurance panel.
GBG has a track record of producing strong operating results, as demonstrated by its weighted average combined ratio of 89.2% and a return on equity of 21.0%, reported between financial years 2014 and 2017. In 2017, the company’s expense ratio rose to 43.0% (2016: 33.1%) as a result of an impairment allowance that it reported in relation to the restructure of its business in
A.M. Best’s assessment of GBG’s business profile reflects its relatively small size and concentration in the international health insurance market segment. The company maintains good geographical diversification but faces material competition from larger international players. GBG has taken steps to enhance its ERM and corporate governance following its public listing in 2017. Nonetheless, it has yet to demonstrate a comprehensive risk framework that appropriately matches its high operational risk profile, given its wide-spread operations.
This press release relates to Credit Ratings that have been published on A.M. Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see A.M. Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Understanding Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and
Copyright © 2018 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180831005229/en/
Senior Financial Analyst
valeria.ermakova@ambest.com
or
Manager, Public Relations
christopher.sharkey@ambest.com
or
Tim Prince, +44 20-7397-0320
Director, Analytics
timothy.prince@ambest.com
or
Director, Public Relations
james.peavy@ambest.com
Source:


Laboratry Equipment
Nominee hints at doubts on ACA challenge; Senate Dems press Kavanaugh on health law
Advisor News
- Helping clients prepare for one of their biggest retirement expenses
- Important year-end financial conversations every advisor must have
- What happens to insurance planning when a client retires early?
- Ask the right questions to turn clients into raving fans
- The first 5 years of your career could determine the next 50
More Advisor NewsAnnuity News
- What lower interest rates mean to annuity payouts
- AM Best downgrades A-Cap insurers amid financial and regulatory troubles
- Lawsuit claims Delaware Life hid billions in insurer-linked investments
- AM Best to Deliver Presentation at 2026 ACLI Annual Conference
- Global Atlantic Announces Launch of ForeLifetime Income, a New Fixed Index Annuity
More Annuity NewsHealth/Employee Benefits News
Life Insurance News